Divestiture = Disposal!Not only did Thomvest dispose of this, they paid Kedrion 31.5M to take it away ensuring that there would be no further revenue. Thomvest almost finished winding Liminal down and getting everything in private hands to develop there. Not much longer before Liminial is done.
“This transaction is also another key milestone in completing the divestiture of our remaining plasma-derived therapeutics business to Kedrion.”